Found 121 matches for
Award Ophthalmology SCNi
16 May 2019
The Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows.
Ophthalmology Public engagement Research
21 March 2019
Researchers in our Sleep and Circadian Neuroscience Institute are working with Havant & South Downs College on a teenage sleep study.
19 February 2019
Researchers in Oxford have carried out the world’s first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD), the UK’s most common cause of sight loss.
Award Ophthalmology SCNi
28 January 2019
Priya Maharaj has won the Archibald Jackson Prize from Somerville College for achieving a Distinction in the MSc in Sleep Medicine.
19 November 2018
Bertil Damato will oversee the provision of clinical care to patients with an ocular tumour and develop a research group to focus on ocular melanoma and other eye tumours.
8 October 2018
The positive results of the world’s first gene therapy trial for a genetic cause of blindness known as choroideremia have been reported in this week’s edition of Nature Medicine.
30 September 2018
Millions of people are to be given access to digital treatment for insomnia as an alternative to sleeping pills. Study by Colin Espie et al shows that Sleepio improves wellbeing in nearly three quarters of participants.
18 June 2018
The first trial of robot-assisted eye surgery in patients has shown the technique to be both safe and effective.
12 March 2018
Researchers at the Sleep and Circadian Neuroscience Institute (SCNi) have been working with visual artist Martin Kohout to reveal the stories of the night-shift workers who keep London running.
3 October 2017
In a laboratory study in Oxford, researchers have shown how it might be possible to reverse blindness using gene therapy to reprogram cells at the back of the eye to become light sensitive.
Clinical Neurology Integrative Neuroimaging Ophthalmology Staff development
8 September 2017
20 March 2017
Researchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people.
3 January 2017
Circadian Therapeutics has been established to identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.
10 November 2016
The trial involves injecting a virus into the eye to deliver billions of healthy genes to replace a key missing gene for choroideremia sufferers.
13 September 2016
University of Oxford surgeons at Oxford's John Radcliffe Hospital have performed the world's first operation inside the eye using a robot.
Clinical Neurology Ophthalmology Research
9 August 2016
A spinout company from our Department, OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.
15 June 2016
Our researchers have shown how different colours of light could affect our ability to sleep.
29 April 2016
Pioneering gene therapy has restored some vision to John Radcliffe Hospital patients with a rare form of genetic blindness for as long as four years, raising hopes it could be used to cure common causes of vision loss, new University of Oxford research published today shows.
31 March 2016
Experts call for introduction of sleep guidelines in new report
2 March 2016